Bioventus (BVS) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.
- Bioventus' Enterprise Value rose 7981.52% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year increase of 7981.52%. This contributed to the annual value of -$3.9 million for FY2024, which is 13709.17% down from last year.
- Per Bioventus' latest filing, its Enterprise Value stood at -$1.0 million for Q3 2025, which was up 7981.52% from $7.1 million recorded in Q2 2025.
- Bioventus' 5-year Enterprise Value high stood at $91.5 million for Q4 2021, and its period low was -$62.3 million during Q3 2021.
- For the 5-year period, Bioventus' Enterprise Value averaged around $7.7 million, with its median value being $7.1 million (2025).
- As far as peak fluctuations go, Bioventus' Enterprise Value skyrocketed by 151667.89% in 2023, and later plummeted by 13709.17% in 2024.
- Over the past 5 years, Bioventus' Enterprise Value (Quarter) stood at $91.5 million in 2021, then tumbled by 37.93% to $56.8 million in 2022, then plummeted by 81.39% to $10.6 million in 2023, then tumbled by 137.09% to -$3.9 million in 2024, then soared by 74.35% to -$1.0 million in 2025.
- Its last three reported values are -$1.0 million in Q3 2025, $7.1 million for Q2 2025, and $14.5 million during Q1 2025.